TECTONIC THERAPEUTIC, INC. Proceeds from Stock Options Exercised
TECTONIC THERAPEUTIC, INC. (TECX) reported Proceeds from Stock Options Exercised of $144.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2026-08-06
- TECTONIC THERAPEUTIC, INC. proceeds from stock options exercised for the quarter ending 2026-06-30 was $44.00K, a 77.32% decline year-over-year.
- TECTONIC THERAPEUTIC, INC. proceeds from stock options exercised for the quarter ending 2026-03-31 was $100.00K, a 89.71% decline year-over-year.
- TECTONIC THERAPEUTIC, INC. proceeds from stock options exercised for the quarter ending 2025-12-31 was $59.00K, a 93.44% decline year-over-year.
- TECTONIC THERAPEUTIC, INC. proceeds from stock options exercised for the quarter ending 2025-09-30 was $6.00K, a 92.21% decline year-over-year.
- TECTONIC THERAPEUTIC, INC. proceeds from stock options exercised for fiscal 2025 was $1.23M, a 24.20% decline from fiscal 2024.
- TECTONIC THERAPEUTIC, INC. proceeds from stock options exercised for fiscal 2024 was $1.62M, a 1242.15% increase from fiscal 2023.
- TECTONIC THERAPEUTIC, INC. proceeds from stock options exercised for fiscal 2023 was $121.00K, a 108.62% increase from fiscal 2022.
- TECTONIC THERAPEUTIC, INC. proceeds from stock options exercised for fiscal 2022 was $58.00K, a 93.70% decline from fiscal 2021.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 3 month as first filed | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 6 month as first filed | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 9 month as first filed | Proceeds from Stock Options Exercised 12 month | Proceeds from Stock Options Exercised 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $44.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $144.00K 10-Q · filed 2026-08-06 | $203.00K derived: sum of 3 quarters · filed 2026-08-06 | $209.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $100.00K 10-Q · filed 2026-05-07 | $159.00K derived: sum of 2 quarters · filed 2026-05-07 | $165.00K derived: sum of 3 quarters · filed 2026-05-07 | $359.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $65.00K derived: sum of 2 quarters · filed 2026-02-26 | $259.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.23M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $200.00K derived: sum of 2 quarters · filed 2026-08-06 | $1.17M 10-Q · filed 2025-11-06 | $2.07M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $194.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.17M 10-Q · filed 2026-08-06 | $2.06M derived: sum of 3 quarters · filed 2026-08-06 | $2.14M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $972.00K 10-Q · filed 2026-05-07 | $1.87M derived: sum of 2 quarters · filed 2026-05-07 | $1.95M derived: sum of 3 quarters · filed 2026-05-07 | $2.59M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $899.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $976.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.62M derived: sum of 3 quarters · filed 2026-02-26 | $1.62M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $77.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $721.00K derived: sum of 2 quarters · filed 2025-11-06 | $725.00K 10-Q · filed 2025-11-06 | $845.00K derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | $644.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $648.00K 10-Q · filed 2025-08-07 | $768.00K derived: sum of 3 quarters · filed 2025-08-07 | $768.00K derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | $4.00K 10-Q · filed 2025-05-08 | $26.00K 10-Q · filed 2024-05-09 | $124.00K derived: sum of 2 quarters · filed 2025-05-08 | $124.00K derived: sum of 3 quarters · filed 2025-05-08 | $83.00K derived: sum of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | $120.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $120.00K derived: sum of 2 quarters · filed 2025-03-20 | $79.00K derived: sum of 3 quarters · filed 2025-03-20 | $121.00K 10-K · filed 2025-03-20 | $235.00K 10-K · filed 2024-03-14 | |||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$41.00K derived: sum of 2 quarters · filed 2024-11-12 | $1.00K 10-Q · filed 2024-11-12 | $176.00K 10-Q · filed 2023-11-09 | $59.00K derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | -$41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $1.00K 10-Q · filed 2024-08-14 | $71.00K 10-Q · filed 2023-08-10 | $59.00K derived: sum of 3 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $42.00K 10-Q · filed 2024-05-09 | $100.00K derived: sum of 2 quarters · filed 2024-05-09 | ||||||
| 2022-12-31 | $58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $58.00K 10-K · filed 2024-03-14 | ||||||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-09 | |||||||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 | $48.00K derived: sum of 2 quarters · filed 2023-05-11 | $70.00K derived: sum of 3 quarters · filed 2023-05-11 | $70.00K derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $70.00K derived: sum of 2 quarters · filed 2023-03-23 | $70.00K derived: sum of 3 quarters · filed 2023-03-23 | $920.00K 10-K · filed 2023-03-23 | ||||
| 2021-09-30 | $22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $22.00K derived: sum of 2 quarters · filed 2022-11-08 | $872.00K 10-Q · filed 2022-11-08 | $986.00K derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $850.00K 10-Q · filed 2022-08-09 | $964.00K derived: sum of 3 quarters · filed 2022-08-09 | $1.02M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | $850.00K 10-Q · filed 2022-05-10 | $964.00K derived: sum of 2 quarters · filed 2022-05-10 | $1.02M derived: sum of 3 quarters · filed 2022-05-10 | $1.08M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | $114.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $174.00K derived: sum of 2 quarters · filed 2022-03-17 | $235.00K derived: sum of 3 quarters · filed 2022-03-17 | $270.00K 10-K · filed 2022-03-17 | ||||
| 2020-09-30 | $60.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $121.00K derived: sum of 2 quarters · filed 2021-11-04 | $156.00K 10-Q · filed 2021-11-04 | $159.00K derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $61.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $96.00K 10-Q · filed 2021-08-05 | $99.00K derived: sum of 3 quarters · filed 2021-08-05 | $108.00K derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | $35.00K 10-Q · filed 2021-05-13 | $38.00K derived: sum of 2 quarters · filed 2021-05-13 | $47.00K derived: sum of 3 quarters · filed 2021-05-13 | $285.00K derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $12.00K derived: sum of 2 quarters · filed 2021-03-18 | $250.00K derived: sum of 3 quarters · filed 2021-03-18 | $502.00K 10-K · filed 2021-03-18 | ||||
| 2019-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $247.00K derived: sum of 2 quarters · filed 2020-11-05 | $499.00K 10-Q · filed 2020-11-05 | |||||
| 2019-06-30 | $238.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $490.00K 10-Q · filed 2020-08-06 | ||||||
| 2019-03-31 | $252.00K 10-Q · filed 2020-05-07 | |||||||
| 2018-12-31 | $17.00K 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |